Rubrofusarin-6-β-gentiobioside inhibits lipid accumulation and weight gain by regulating AMPK/mTOR signaling
ConclusionRFG can ameliorate obesity, and thus, could be used as a therapeutic agent for treating obesity.Graphical abstract
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research
More News: Diets | Drugs & Pharmacology | Eating Disorders & Weight Management | Fatty Liver Disease (FLD) | High Fat | Liver | Nutrition | Obesity | Stem Cell Therapy | Stem Cells | Study | Urology & Nephrology